HBSS, Hanks' Balanced Salt Solution

  • 文章类型: Journal Article
    未经证实:心脏病是全世界死亡的主要原因,近年来,每年因心脏病死亡的人数有所增加。虽然心力衰竭通常用药物治疗,终末期疾病的最终治疗方法是心脏移植或人造心脏。然而,这些手术策略的使用受到血栓形成等问题的限制,拒绝和捐助者短缺。再生疗法,例如使用组织工程技术构建的培养细胞和组织的移植,作为心力衰竭的替代疗法受到了极大的关注。对源自人诱导多能干细胞(hiPSC-CM)的心肌细胞的潜在临床应用的研究正在进行中。然而,由于不成熟和对葡萄糖代谢的依赖,在先前培养条件下维持的心肌细胞的能量产生能力低于成年原代心肌细胞。因此,这项研究的目的是比较培养的心肌细胞和体内心脏细胞之间代谢的脂肪酸类型,并研究向培养基中添加脂肪酸是否会影响心肌细胞的能量产生。
    UNASSIGNED:基于对大鼠原代心肌细胞(rat-CM)脂肪酸消耗的分析,开发了一种含脂肪酸的培养基,和该培养基对三磷酸腺苷(ATP)生产的影响通过生物发光成像的萤光素酶表达的大鼠CMs进行了研究。基于对猪心脏和hiPSC-CM脂肪酸利用的分析,进一步调整培养基的脂肪酸含量,进行氧消耗分析以探索含脂肪酸的培养基是否诱导hiPSC-CM从无氧代谢转变为有氧代谢。此外,评价培养基对hiPSC-CM来源的组织产生的收缩力的影响。
    未经证实:大鼠血清,人血清和猪血浆含有相似类型的脂肪酸(油酸,硬脂酸,亚油酸,棕榈酸和花生四烯酸)。在大鼠-CM之间消耗的脂肪酸类型也相似,hiPSC-CM和猪心脏。向培养基中添加脂肪酸增加了表达荧光素酶的大鼠CMs的生物发光(ATP水平的间接测量),HiPSC-CM的耗氧量,和由hiPSC-CM构建的心脏组织产生的收缩力。
    UNASSIGNED:hiPSC-CM代谢与大鼠CM和猪心脏消耗的脂肪酸相似。此外,在培养基中添加这些脂肪酸增加了大鼠-CM和hiPSC-CM的能量产生,并增强了hiPSC-CM产生的心肌组织的收缩性。这些发现表明,在培养基中添加脂肪酸通过β-氧化刺激心肌细胞的有氧能量产生。由于在标准培养基中培养的心肌细胞主要依赖于厌氧葡萄糖代谢并保持在未成熟状态,值得进一步研究以确定在培养基中添加脂肪酸是否会提高由这些细胞构建的hiPSC-CM和心脏组织的能量产生能力和成熟度。有可能优化培养心肌细胞的代谢,这需要高能量生产来维持它们的收缩功能,将改善hiPSC-CM衍生组织的性质,让它更好地用于疾病建模,心力衰竭的药物筛查和再生治疗。
    UNASSIGNED: Heart disease is a major cause of mortality worldwide, and the annual number of deaths due to heart disease has increased in recent years. Although heart failure is usually managed with medicines, the ultimate treatment for end-stage disease is heart transplantation or an artificial heart. However, the use of these surgical strategies is limited by issues such as thrombosis, rejection and donor shortages. Regenerative therapies, such as the transplantation of cultured cells and tissues constructed using tissue engineering techniques, are receiving great attention as possible alternative treatments for heart failure. Research is ongoing into the potential clinical use of cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs). However, the energy-producing capacity of cardiomyocytes maintained under previous culture conditions is lower than that of adult primary cardiomyocytes due to immaturity and a reliance on glucose metabolism. Therefore, the aims of this study were to compare the types of fatty acids metabolized between cardiomyocytes in culture and heart cells in vivo and investigate whether the addition of fatty acids to the culture medium affected energy production by cardiomyocytes.
    UNASSIGNED: A fatty acid-containing medium was developed based on an analysis of fatty acid consumption by rat primary cardiomyocytes (rat-CMs), and the effects of this medium on adenosine triphosphate (ATP) production were investigated through bioluminescence imaging of luciferase-expressing rat-CMs. Next, the fatty acid content of the medium was further adjusted based on analyses of fatty acid utilization by porcine hearts and hiPSC-CMs. Oxygen consumption analyses were performed to explore whether the fatty acid-containing medium induced hiPSC-CMs to switch from anaerobic metabolism to aerobic metabolism. Furthermore, the effects of the medium on contractile force generated by hiPSC-CM-derived tissue were evaluated.
    UNASSIGNED: Rat serum, human serum and porcine plasma contained similar types of fatty acid (oleic acid, stearic acid, linoleic acid, palmitic acid and arachidonic acid). The types of fatty acid consumed were also similar between rat-CMs, hiPSC-CMs and porcine heart. The addition of fatty acids to the culture medium increased the bioluminescence of luciferase-expressing rat-CMs (an indirect measure of ATP level), oxygen consumption by hiPSC-CMs, and contractile force generated by cardiac tissues constructed from hiPSC-CMs.
    UNASSIGNED: hiPSC-CMs metabolize similar types of fatty acid to those consumed by rat-CMs and porcine hearts. Furthermore, the addition of these fatty acids to the culture medium increased energy production by rat-CMs and hiPSC-CMs and enhanced the contractility of myocardial tissue generated from hiPSC-CMs. These findings suggest that the addition of fatty acids to the culture medium stimulates aerobic energy production by cardiomyocytes through β-oxidation. Since cardiomyocytes cultured in standard media rely primarily on anaerobic glucose metabolism and remain in an immature state, further research is merited to establish whether the addition of fatty acids to the culture medium would improve the energy-producing capacity and maturity of hiPSC-CMs and cardiac tissue constructed from these cells. It is possible that optimizing the metabolism of cultured cardiomyocytes, which require high energy production to sustain their contractile function, will improve the properties of hiPSC-CM-derived tissue, allowing it to be better utilized for disease modeling, drug screening and regenerative therapies for heart failure.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    中心体在分化的神经元中缺乏微管(MT)成核活性。我们先前已经证明MT在小鼠神经元的细胞质中成核。它们应该为枝晶生长所需的MTs提供种子。然而,激活细胞质γ-微管蛋白环复合物(γTuRC)的因素尚不清楚。在这里,我们报告了细胞周期蛋白依赖性激酶5调节亚基相关蛋白2(CKD5RAP2)的可变剪接同工型,作为细胞质γTuRC激活剂的候选物。该同工型缺乏外显子17,主要在大脑和睾丸中表达。在皮质神经元发育过程中表达是短暂的,这一时期与我们报道的细胞质MT成核时期相吻合。该同种型导致移码并产生截短的蛋白质,而没有中心体定位信号。当这种同工型在细胞中表达时,它弥漫地定位于细胞质中。它与γ-微管蛋白和MOZART2共免疫沉淀,表明它可以激活胞质γTuRC。在MTs的冷-nocodazole解聚和随后的冲洗后,我们在转染了该同种型cDNA的细胞的细胞质中观察到许多短MTs。同工型过表达细胞表现出MT的数量增加和乙酰化微管蛋白的比例降低,表明同工型增强了MT的产生和周转。我们的数据表明CDK5RAP2的可变剪接在发育中的神经元中诱导MT的细胞质成核的可能性。
    The centrosome lacks microtubule (MT)-nucleation activity in differentiated neurons. We have previously demonstrated that MTs were nucleated at the cytoplasm of mouse neurons. They are supposed to serve seeds for MTs required for dendrite growth. However, the factors that activate the cytoplasmic γ-tubulin ring complex (γTuRC) are unknown. Here we report an alternative splicing isoform of cyclin-dependent kinase 5 regulatory subunit-associated protein 2 (CKD5RAP2) as a candidate for the cytoplasmic γTuRC activator. This isoform lacked exon 17 and was expressed predominantly in the brain and testis. The expression was transient during the development of cortical neurons, which period coincided with the period we reported cytoplasmic MT nucleation. This isoform resulted in a frameshift and generated truncated protein without a centrosomal localization signal. When this isoform was expressed in cells, it localized diffusely in the cytoplasm. It was co-immunoprecipitated with γ-tubulin and MOZART2, suggesting that it can activate cytosolic γTuRCs. After cold-nocodazole depolymerization of MTs and subsequent washout, we observed numerous short MTs in the cytoplasm of cells transfected with the cDNA of this isoform. The isoform-overexpressing cells exhibited an increased amount of MTs and a decreased ratio of acetylated tubulin, suggesting that MT generation and turnover were enhanced by the isoform. Our data suggest the possibility that alternative splicing of CDK5RAP2 induces cytoplasmic nucleation of MTs in developing neurons.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经证实:肺移植是许多不可逆肺损伤患者唯一有效的治疗选择,全球对肺移植的需求正在增加,预计将继续超过可用供体的数量。肺泡上皮细胞(AECs)的再生疗法有望作为器官移植的替代选择。AECs通常与小鼠来源的3T3饲养细胞共培养,但使用异种组织进行再生治疗会引起安全性问题.在无进料条件下制造AEC片材将避免这些安全问题。我们描述了一种新型的无饲养器制造AEC片的方法,该方法可能适用于肺再生治疗。
    UNASSIGNED:将从雄性近交大鼠或表达绿色荧光蛋白(GFP)的转基因大鼠切除的肺组织切碎并用弹性蛋白酶解离。根据低钙培养基(LCM)中是否包含rho激酶(ROCK)抑制剂以及组织培养皿是否用重组层粘连蛋白-511E8片段(rLN511E8)包被,在四种不同的无饲养条件下培养分离的AECs。将扩增的细胞在温度响应的培养皿上培养,随后收获为AEC片。在无胸腺大鼠中评估GFP-AEC片移植到左肺部分切除区域后的植入。
    未经证实:AECs在含有ROCK抑制剂的LCM中在涂有rLN511E8的组织培养皿中培养时增殖并达到汇合。当同时使用ROCK抑制剂和rLN511E8包被的培养皿时,培养7天后获得的AECs数量明显高于其他三组。免疫组织化学分析显示水通道蛋白-5,表面活性剂蛋白(SP)-A,SP-C,SP-D和Axin-2由培养的AECs表达。当将扩增的AECs在LCMROCK抑制剂中培养7天,然后在补充有200mg/L氯化钙的LCMROCK抑制剂中培养3天时,从温度响应性培养皿中成功收获AEC片(通过降低温度)。在移植到肺缺损上7天后将AEC片牢固地移植并表达AEC标记蛋白。
    UNASSIGNED:在无饲养条件下制造的AEC片在体内移植到肺后保留了AEC的特征。该技术的进一步改进可以允许肺泡样组织的生物工程用于肺再生治疗。
    UNASSIGNED: Lung transplantation is the only effective treatment option for many patients with irreversible pulmonary injury, and the demand for lung transplantation is increasing worldwide and expected to continue to outstrip the number of available donors. Regenerative therapy with alveolar epithelial cells (AECs) holds promise as an alternative option to organ transplantation. AECs are usually co-cultured with mouse-derived 3T3 feeder cells, but the use of xenogeneic tissues for regenerative therapy raises safety concerns. Fabrication of AEC sheets under feeder-free conditions would avoid these safety issues. We describe a novel feeder-free method of fabricating AEC sheets that may be suitable for pulmonary regenerative therapy.
    UNASSIGNED: Lung tissues excised from male outbred rats or transgenic rats expressing green fluorescent protein (GFP) were finely minced and dissociated with elastase. The isolated AECs were cultured under four different feeder-free conditions according to whether a rho kinase (ROCK) inhibitor was included in the low-calcium medium (LCM) and whether the tissue culture dish was coated with recombinant laminin-511 E8 fragment (rLN511E8). The expanded cells were cultured on temperature-responsive dishes and subsequently harvested as AEC sheets. Engraftment of GFP-AEC sheets after their transplantation onto a partially resected region of the left lung was assessed in athymic rats.
    UNASSIGNED: AECs proliferated and reached confluence when cultured in LCM containing a ROCK inhibitor on tissue culture dishes coated with rLN511E8. When both the ROCK inhibitor and rLN511E8-coated culture dish were used, the number of AECs obtained after 7 days of culture was significantly higher than that in the other three groups. Immunohistochemical analyses revealed that aquaporin-5, surfactant protein (SP)-A, SP-C, SP-D and Axin-2 were expressed by the cultured AECs. AEC sheets were harvested successfully from temperature-responsive culture dishes (by lowering the temperature) when the expanded AECs were cultured for 7 days in LCM + ROCK inhibitor and then for 3 days in LCM + ROCK inhibitor supplemented with 200 mg/L calcium chloride. The AEC sheets were firmly engrafted 7 days after transplantation onto the lung defect and expressed AEC marker proteins.
    UNASSIGNED: AEC sheets fabricated under feeder-free conditions retained the features of AECs after transplantation onto the lung in vivo. Further improvement of this technique may allow the bioengineering of alveolar-like tissue for use in pulmonary regenerative therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在大多数多光谱光学分辨率光声显微镜(OR-PAM)中,对每个激发波长重复空间扫描,这降低了吞吐量并在频谱处理期间导致运动伪影。这项研究提出了一种新的光谱OR-PAM技术,以从单个空间扫描中获取有关光声信号强度和激发波长的信息。该技术涉及用具有和不具有波长相关时间延迟的两个宽带光脉冲照射成像目标。然后通过测量由两个光脉冲产生的光声信号之间的时间延迟来计算样品的激发波长。通过测量管中染料的激发波长来验证该技术。此外,我们展示了用合适的染料染色的细胞的三维光谱OR-PAM。尽管必须根据应用调整励磁效率和励磁带宽之间的折衷,将所提出的技术与快速空间扫描方法相结合,可以为最近的OR-PAM应用做出显著贡献,如监测快速生物事件和移动材料的微观跟踪。
    In most multispectral optical-resolution photoacoustic microscopy (OR-PAM), spatial scanning is repeated for each excitation wavelength, which decreases throughput and causes motion artifacts during spectral processing. This study proposes a new spectroscopic OR-PAM technique to acquire information on the photoacoustic signal intensity and excitation wavelength from single spatial scans. The technique involves irradiating an imaging target with two broadband optical pulses with and without wavelength-dependent time delays. The excitation wavelength of the sample is then calculated by measuring the time delay between the photoacoustic signals generated by the two optical pulses. This technique is validated by measuring the excitation wavelengths of dyes in tubes. Furthermore, we demonstrate the three-dimensional spectroscopic OR-PAM of cells stained with suitable dyes. Although the tradeoff between excitation efficiency and excitation bandwidth must be adjusted based on the application, combining the proposed technique with fast spatial scanning methods can significantly contribute to recent OR-PAM applications, such as monitoring quick biological events and microscale tracking of moving materials.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:藤素是一种外源性人参衍生的G蛋白偶联溶血磷脂酸(LPA)受体配体。LPA通过神经元LPA1受体诱导体外形态学变化和迁移。最近,我们报道,全身给药人参皂甙可通过细胞旁通路增加血脑屏障(BBB)通透性,并增加其与脑神经元的结合.然而,关于脑内皮素对体内神经元形态和迁移的影响知之甚少。
    方法:我们使用原代海马神经前体细胞(hNPC)检查了Gintonin对体外迁移和形态的影响,并使用实时显微镜分析和免疫组织化学分析检查了Gintonin对成年脑神经元的体内作用,以观察Gintonin治疗引起的形态和位置变化。
    结果:我们发现,用金霉素处理hNPC会诱导细胞聚集后细胞变圆的形态学变化,并随时间复发返回单个神经元。然而,Gintonin对hNPCs的体外作用被LPA1/3受体拮抗剂阻断,Ki16425和Rho激酶抑制剂,Y27632。我们还使用抗NeuN和-神经丝H抗体检查了红蛋白对成年小鼠大脑中神经元形态变化和迁移的体内影响。我们发现,急性静脉内注射金托宁可引起大脑神经元的形态和迁移变化。Gintonin诱导皮层中神经丝H缩短的神经元迁移。Ki16425也阻断了Gintonin的体内作用。
    结论:本报告提出了一种可能性,它可以进入大脑并对成年小鼠脑神经元的迁移和形态产生影响,并可能解释了在给药过程中神经疾病的治疗作用。
    BACKGROUND: Gintonin is an exogenous ginseng-derived G-protein-coupled lysophosphatidic acid (LPA) receptor ligand. LPA induces in vitro morphological changes and migration through neuronal LPA1 receptor. Recently, we reported that systemic administration of gintonin increases blood-brain barrier (BBB) permeability via the paracellular pathway and its binding to brain neurons. However, little is known about the influences of gintonin on in vivo neuron morphology and migration in the brain.
    METHODS: We examined the effects of gintonin on in vitro migration and morphology using primary hippocampal neural precursor cells (hNPC) and in vivo effects of gintonin on adult brain neurons using real time microscopic analysis and immunohistochemical analysis to observe the morphological and locational changes induced by gintonin treatment.
    RESULTS: We found that treating hNPCs with gintonin induced morphological changes with a cell rounding following cell aggregation and return to individual neurons with time relapses. However, the in vitro effects of gintonin on hNPCs were blocked by the LPA1/3 receptor antagonist, Ki16425, and Rho kinase inhibitor, Y27632. We also examined the in vivo effects of gintonin on the morphological changes and migration of neurons in adult mouse brains using anti-NeuN and -neurofilament H antibodies. We found that acute intravenous administration of gintonin induced morphological and migrational changes in brain neurons. Gintonin induced some migrations of neurons with shortened neurofilament H in the cortex. The in vivo effects of gintonin were also blocked by Ki16425.
    CONCLUSIONS: The present report raises the possibility that gintonin could enter the brain and exert its influences on the migration and morphology of adult mouse brain neurons and possibly explains the therapeutic effects of neurological diseases behind the gintonin administration.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    通常使用的聚乙二醇(PEG)是分子量(MW)分布在其名称中应用的平均值附近的多分散分子,例如,PEG4000。先前的研究表明,PEG可以作为P-糖蛋白(P-gp)抑制剂,有可能影响伴随给药的药物的吸收和流出。然而,与PEG的细胞摄取机制和P-gp的确切作用有关的问题尚未解决。在这项研究中,我们研究了MDCK模拟细胞摄取PEG的机制,特别是,MDCK-hMDR1和A549细胞对分子量和与P-gp相互作用的影响。结果表明:(a)P-gp抑制剂增强了MDCK-hMDR1细胞对PEG的摄取;(b)PEG刺激P-gpATPase活性,但程度远低于维拉帕米;(c)低分子量(<2000Da)的PEG的摄取是通过被动扩散发生的,而高分子量(>5000Da)的PEG的摄取是通过被动细胞内扩散和腔细胞介导的组合发生的。这些发现表明PEG可以参与基于P-gp的药物相互作用,我们认为当使用PEG作为赋形剂以及在PEG化药物和药物递送系统中使用时,应该考虑这些相互作用。
    Polyethylene glycols (PEGs) in general use are polydisperse molecules with molecular weight (MW) distributed around an average value applied in their designation e.g., PEG 4000. Previous research has shown that PEGs can act as P-glycoprotein (P-gp) inhibitors with the potential to affect the absorption and efflux of concomitantly administered drugs. However, questions related to the mechanism of cellular uptake of PEGs and the exact role played by P-gp has not been addressed. In this study, we examined the mechanism of uptake of PEGs by MDCK-mock cells, in particular, the effect of MW and interaction with P-gp by MDCK-hMDR1 and A549 cells. The results show that: (a) the uptake of PEGs by MDCK-hMDR1 cells is enhanced by P-gp inhibitors; (b) PEGs stimulate P-gp ATPase activity but to a much lesser extent than verapamil; and (c) uptake of PEGs of low MW (<2000 Da) occurs by passive diffusion whereas uptake of PEGs of high MW (>5000 Da) occurs by a combination of passive diffusion and caveolae-mediated endocytosis. These findings suggest that PEGs can engage in P-gp-based drug interactions which we believe should be taken into account when using PEGs as excipients and in PEGylated drugs and drug delivery systems.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    Keratinocyte line cells HaCaT and FEPE1L-8 are used for skin model with type I collagen fibrils (gels). For this purpose, not only differentiation but also regulation of proliferation on type I collagen gels by exogenous calcium concentration is important. When exogenous calcium concentration is low, primary keratinocyte proliferation is repressed and eventually cells are induced to apoptosis on type I collagen gels. The apoptosis induced on type I collagen gels is suppressed by increasing calcium concentration in the medium. That is, higher exogenous calcium concentration is necessary for primary keratinocyte survival on type I collagen gels than for that on dish surface culture. Meanwhile much higher exogenous calcium causes cell differentiation and inhibition of proliferation. The optimal calcium concentrations for proliferation on type I collagen gels have not been clarified in keratinocyte line cells. HaCaT cells have a unique calcium sensitivity in comparison with primary keratinocytes, whereas FEPE1L-8 cells have a similar sensitivity to primary keratinocytes. In this study, we compared the effect of calcium concentrations on proliferation of HaCaT and FEPE1L-8 cells on type I collagen gels. On type I collagen gels, both line cells required higher calcium concentrations for proliferation than on dish surface. HaCaT cells proliferated better in a wider range of calcium concentrations than FEPE1L-8 cells.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    Enrichment of tissues with ≥20-carbon n-3 PUFA like EPA is associated with positive cardiovascular outcomes. Stearidonic acid (SDA; 18 : 4n-3) and α-linolenic acid (ALA; 18 : 3n-3) are plant-derived dietary n-3 PUFA; however, direct comparisons of their impact on tissue n-3 PUFA content are lacking. Ahiflower(®) oil extracted from Buglossoides arvensis seeds is the richest known non-genetically modified source of dietary SDA. To investigate the safety and efficacy of dietary Ahiflower oil, a parallel-group, randomised, double-blind, comparator-controlled phase I clinical trial was performed. Diets of healthy subjects (n 40) were supplemented for 28 d with 9·1 g/d of Ahiflower (46 % ALA, 20 % SDA) or flax seed oil (59 % ALA). Blood and urine chemistries, blood lipid profiles, hepatic and renal function tests and haematology were measured as safety parameters. The fatty acid composition of fasting plasma, erythrocytes, polymorphonuclear cells and mononuclear cells were measured at baseline and after 14 and 28 d of supplementation. No clinically significant changes in safety parameters were measured in either group. Tissue ALA and EPA content increased in both groups compared with baseline, but EPA accrual in plasma and in all cell types was greater in the Ahiflower group (time × treatment interactions, P ≤ 0·01). Plasma and mononuclear cell eicosatetraenoic acid (20 : 4n-3) and docosapentaenoic acid (22 : 5n-3) content also increased significantly in the Ahiflower group compared with the flax group. In conclusion, the consumption of Ahiflower oil is safe and is more effective for the enrichment of tissues with 20- and 22-carbon n-3 PUFA than flax seed oil.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号